Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Betamethasone acetate |
Is a |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phosphate |
Is a |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone benzoate |
Is a |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing clobetasol (medicinal product) |
Is a |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone dipropionate |
Is a |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone adverse reaction |
Causative agent (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Augmented betamethasone dipropionate |
Is a |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clobetasol propionate |
Is a |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone ester |
Is a |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone allergy |
Causative agent (attribute) |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing betamethasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intramuscular injection of betamethasone |
Direct substance |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone 500micrograms soluble tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
bétaméthasone 4 mg/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone 0.1% scalp application (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone 0.1% cream (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone 0.1% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone 0.1% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone+salicylic acid 0.05/3% scalp application |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone 0.05% cream (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone + antimicrobials |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone+neomycin sulfate 0.1/0.5% ointment (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone+clotrimazole 0.05/1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing betamethasone and clioquinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone- and clotrimazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing betamethasone and fusidic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone+neomycin sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing betamethasone and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Topical betamethasone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing betamethasone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Parenteral betamethasone (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betamethasone 600 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone 0.6mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone dipropionate + clotrimazole 0.64mg/10mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone dipropionate + clotrimazole ns/10mg lotion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone+calcipotriol (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone valerate |
Is a |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phospha 3mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phosphate 4mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone dipropionate + clotrimazole ns/10mg lotion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone- and neomycin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing betamethasone in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intramuscular injection of betamethasone |
Direct substance |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Measurement of betamethasone (procedure) |
Component |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone allergy |
Causative agent (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone 500 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betamethasone 600 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betamethasone 600 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone dipropionate |
Is modification of (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone valerate |
Is modification of (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone benzoate |
Is modification of (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone acetate |
Is modification of (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phosphate |
Is modification of (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone 600 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone 500 microgram oral tablet |
Has precise active ingredient |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous lotion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous cream |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone (as betamethasone valerate) 1 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone+neomycin sulfate 0.1/0.5% ointment (substance) |
Has basis of strength substance (attribute) |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops |
Has basis of strength substance (attribute) |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing betamethasone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing betamethasone and salicylic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing betamethasone and fusidic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone- and neomycin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone- and clotrimazole-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone- and neomycin-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone and clotrimazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only betamethasone and fusidic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone and calcipotriol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only betamethasone and clioquinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only betamethasone and neomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betamethasone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |